Palo Alto, CA, and Research Triangle Park, NC, July 26, 2023 (Globe Newswire) -- Kriya Therapeutics, Inc., a biopharmaceutical company pioneering transformation gene therapies in opthalmology, Neurology and metabolic disease, announced a $150 million infusion in its Series C Financing. This boost elevates the total Series C round to $430 million, reinforcing Kriya's commitment to transforming the lives of millions worldwide.
Read full article here.
Palo Alto, CA, May 2, 2024 (Globe Newswire) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) recently completed a $200M private financing round for its former subsidiary, TheRas, Inc. d/b/a BridgeBio Oncolo
San Diego, CA, May 2, 2024 (QuidelOrtho) -- Brian J. Blaser has been appointed as the new President and CEO of QuidelOrtho. Most recently overseeing Abbott's global diagnostics organization, he brin
Watertown, MA, May 2, 2024 (finance.yahoo.com) -- Novartis is acquiring Mariana Oncology, a biotech firm specializing in targeted radiation medicines, for $1 billion. Mariana could receive up to $75
